Posted on May 2, 2008 by cartier@bio
My name is Mark Leahey, and I am the Executive Director of the Medical Device Manufacturers Association (MDMA). MDMA is a national trade association representing innovative, entrepreneurial medical technology companies across the country. Our mission is to ensure that patients have timely access to the latest advancements in medical technology, most of which are developed [...]
Filed under: Congress, Non Profit, SBIR | Tagged: MDMA, medical technology, Phase I grants, SBIR | Leave a Comment »
Posted on April 18, 2008 by cartier@bio
It’s been a busy and productive week for SBIR reform advocates. The House Science Subcommittee on Technology and Innovation and the House Small Business Committee both marked up SBIR reauthorization legislation this week and expect to take a bill to the floor mid to late next week (week of 4/21). This is very positive news [...]
Filed under: Congress, SBIR | Tagged: biotech firms, House Science subcommittee, HR 5819, Phase I grants, pipeline, SBIR | Leave a Comment »
